Veena Mathew

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours

Hong Xu, Marco Di Antonio, Steven McKinney et al. · Nature Communications · 2017 · 573 citations · Full text

The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity

Ferdinand Kappes, Tanja Waldmann, Veena Mathew et al. · Genes & Development · 2011 · 100 citations · Full text

Cytogenetics, Genetics, Genomic Mechanism +22

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

The Histone-Fold Protein CHRAC14 Influences Chromatin Composition in Response to DNA Damage

Veena Mathew, Anne‐Laure Pauleau, Natascha Steffen et al. · Cell Reports · 2014 · 31 citations · Full text

Histone Modifications, Dna Damage, Epigenetic Change +20